Detalles de la búsqueda
1.
A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer.
Breast Cancer Res Treat
; 137(3): 755-66, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23283526
2.
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
Cancer
; 104(7): 1442-52, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16116598
Resultados
1 -
2
de 2
1
Próxima >
>>